Apatinib plus chemotherapy shows clinical activity in advancedNSCLC: a retrospective study.Jing Tang1#, Xu Yong Li2#, Jing Bo Lian...
2018 ASCO Rivoceranib (Apatinib) abstracts
AbstractBackground:Apatinib, a novel small molecule vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibi...
AbstractNo definitive treatment strategy has been established for patients with metastatic colorectal cancer (mCRC) who experience...
AbstractOBJECTIVES:Advanced gastric cancer poses a therapeutic challenge worldwide. In randomised clinical trials, anti-VEGF has b...
AbstractApatinib has been proven to be effective and safe among patients in the third-line treatment of advanced gastric cancer in...